Wieneke A. Buikhuisen

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma

Josine M.M.F. Quispel-Janssen, Vincent van der Noort, Jeltje F. de Vries et al. · Journal of Thoracic Oncology · 2018 · 244 citations · Full text

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial

Lee M. Krug, Hedy L. Kindler, Hilary Calvert et al. · The Lancet Oncology · 2015 · 219 citations

Surgical Oncology, Medicine, Previous Chemotherapy +7

Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients

Ekaterina A. Semenova, Min‐Chul Kwon, Kim Monkhorst et al. · Cell Reports · 2016 · 149 citations · Full text

Oncology, Medicine, Tumor Growth +13

High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes.

Barbara Haber, S Chin, Emil Chuang et al. · Journal of Clinical Investigation · 1995 · 139 citations · Full text

Regenerating Liver, Glucose Homeostasis, Cell Cycle +25

Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial

Piero Ferollà, Maria Pia Brizzi, Tim Meyer et al. · The Lancet Oncology · 2017 · 134 citations

Long-acting Pasireotide, Oncology, Medicine +10